CN104041803B - A kind of anti-ageing plant stem cell lozenge and preparation method thereof - Google Patents
A kind of anti-ageing plant stem cell lozenge and preparation method thereof Download PDFInfo
- Publication number
- CN104041803B CN104041803B CN201310080993.3A CN201310080993A CN104041803B CN 104041803 B CN104041803 B CN 104041803B CN 201310080993 A CN201310080993 A CN 201310080993A CN 104041803 B CN104041803 B CN 104041803B
- Authority
- CN
- China
- Prior art keywords
- preparation
- stem cell
- plant stem
- particle
- ageing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000196324 Embryophyta Species 0.000 title claims abstract description 15
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 239000007937 lozenge Substances 0.000 title claims abstract description 12
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 12
- 239000002245 particle Substances 0.000 claims abstract description 18
- 239000000203 mixture Substances 0.000 claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229930182470 glycoside Natural products 0.000 claims abstract description 10
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims abstract description 9
- 229930003944 flavone Natural products 0.000 claims abstract description 9
- -1 flavone glycoside Chemical class 0.000 claims abstract description 9
- 235000011949 flavones Nutrition 0.000 claims abstract description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000003756 stirring Methods 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 239000007779 soft material Substances 0.000 claims abstract description 7
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 6
- 229920002472 Starch Polymers 0.000 claims abstract description 6
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 claims abstract description 6
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 6
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 6
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 6
- 235000019698 starch Nutrition 0.000 claims abstract description 6
- 239000008107 starch Substances 0.000 claims abstract description 6
- 239000012153 distilled water Substances 0.000 claims abstract description 5
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 5
- 238000009288 screen filtration Methods 0.000 claims abstract description 5
- 239000000080 wetting agent Substances 0.000 claims abstract description 5
- 229940032147 starch Drugs 0.000 claims abstract description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 6
- 230000000259 anti-tumor effect Effects 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 abstract description 4
- 230000007170 pathology Effects 0.000 abstract description 3
- 230000001629 suppression Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000607764 Shigella dysenteriae Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 108010084210 citrin Proteins 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 229940007046 shigella dysenteriae Drugs 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000029162 bladder disease Diseases 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008125 glucin Substances 0.000 description 1
- 125000004383 glucosinolate group Chemical group 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000026533 urinary bladder disease Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention patent discloses a kind of anti-ageing plant stem cell lozenge and preparation method thereof; It adopts flavone glycoside, texifolin, agate coffee and Ka Mu fruit to be raw material, mixture is formed by adding starch, low-substituted hydroxypropyl cellulose and microcrystalline cellulose, after mixture stirs, adding ethanol or distilled water carries out stirring until evenly as wetting agent, be made into soft material, go out particle by screen filtration again, add after dolomol mixes after particle is dried, be pressed into sheet and be made into finished product and orally use.The finished product made by said method has the life 20-25 making people, has anti-ageing, antitumor, the function of T suppression cell pathology, can improve sexuality.
Description
Technical field
Patent of the present invention relates to a kind of anti-ageing plant stem cell lozenge and preparation method thereof.
Background technology
Current: along with work, life stress increase, human body there will be inferior health or sick and even suffer from the sick situation such as tumour, existing for the sick rear most employing of human body be operation, have an injection and the way such as chemotherapy, the health brought to patient and psychology are all very large miseries.
Patent of invention content
For overcoming above-mentioned defect, the purpose of design of patent of the present invention is, being provides a kind of anti-ageing plant stem cell lozenge and preparation method thereof, can be used for the growth preventing in advance to resist and check the cell being unfavorable for human body.
For achieving the above object, patent object of the present invention is to provide a kind of anti-ageing plant stem cell lozenge and preparation method thereof; It adopts flavone glycoside, texifolin, agate coffee and Ka Mu fruit to be raw material, mixture is formed by adding starch, low-substituted hydroxypropyl cellulose and microcrystalline cellulose, after mixture stirs, adding ethanol or distilled water carries out stirring until evenly as wetting agent, be made into soft material, go out particle by screen filtration again, add after dolomol mixes after particle is dried, be pressed into sheet and be made into finished product and orally use.The finished product made by said method has the life 20-25 making people, stronger bacteriostasis is had to staphylococcus aureus, Escherichia coli, shigella dysenteriae and typhoid bacillus, the free radical in the person can be removed, have anti-ageing, antitumor, the function of T suppression cell pathology, the sexuality of the male sex, women can be improved, ensure the healthy stable state of sexual gland function.
Further, patent of the present invention adopts flavone glycoside 500g, texifolin 250-500g, agate coffee 250-500g and the Ka Mu fruit 500g being more than or equal to 98% concentration are raw material, form mixture by adding the starch of 2.5-5kg, 0.07-0.1kg low-substituted hydroxypropyl cellulose and 01.1-0.6kg microcrystalline cellulose; After mixture is stirred, adding ethanol or distilled water carries out stirring until evenly as wetting agent, be made into soft material, soft material goes out particle by 14-20 object screen filtration, by dryer, particle is dried, after drying, the standard of particle is the water content of 3-10%, adds after dolomol 150-250g mixes in the particle after oven dry, is pressed into sheet and is made into finished product and orally uses.
Further, in patent of the present invention, dryer remains between 40-100 DEG C the temperature that particle is dried.
Further, the efficient liquid phase spectroscopic methodology of preparation is utilized to prepare the flavone glycoside that concentration is more than or equal to 98% in patent of the present invention from plant total isoflavone extract.
Further, 1936, St.George's found chromocor compound-flavone glycoside, named it to be citrin, and obtained the prize of Nobel's biology.Citrin and agate coffee are that raw material adopts international pharmacy forward position abstraction technique to be made, and are the new resource foods of health ministry approval, safety, healthy without any side effects.Agate coffee is according to French Luo Gaite experimental determination: protein content is more than 14%, the carbohydrate of 59%, the fiber of 8.5%, mineral matter, and containing vitamin C, B1, B2, B6, A, E, B12, B5, fat content is not high but mostly wherein be unrighted acid, and the content of linoleic acid plus linolenic acid reaches more than 53%.Natural activity composition comprises alkaloid, glucosinolate and catabolite isothiocyanic acid benzyl fat, sterol, polyphenols, glycyrrhizic acid glucin, flavone glycoside, glycan, lecithin and sterol, plant VC etc.
Adopt that above-mentioned preparation method is simple to operate, safety, finished product can not only keep vascular wall to have good pliability, erythrocytic activity can also be improved, make it increase oxygen carrier amount and metabolism amount, the adhesion between blood platelet can be suppressed simultaneously, have and improve sanguimotor function; May be used for prevention and therapy diabetes, three high diseases, cholecystopathy, intestines and stomach, prostate, skin disease, kidney and bladder disease, ophthalmology disease etc. and inferior health, and improve antitumor the playing of immunity and alleviate side effect caused by chemotherapy and radiation; The life 20-25 of people can be made; Antibacterial: to have stronger bacteriostasis to staphylococcus aureus, Escherichia coli, shigella dysenteriae and typhoid bacillus; Scavenging free radicals: it has multiple biologically active, can remove the free radical in the person, has anti-ageing, antitumor, the magical function of T suppression cell pathology; Improve fecundity: the sexuality that can improve the male sex, women, ensure the healthy stable state of sexual gland function.
Accompanying drawing explanation
Fig. 1 is the Making programme figure of patent of invention
Detailed description of the invention
Below in conjunction with accompanying drawing, patent of the present invention is described in detail.
As shown in Figure 1, anti-ageing plant stem cell lozenge of the one of patent of the present invention and preparation method thereof; It adopts 1 flavone glycoside 500g, 2 texifolin 250-500g, the 3 agate coffee 250-500g being more than or equal to 98% concentration and 4 card nurses fruit 500g is raw material, forms 8 mixtures by adding 5 starch of 2.5-5kg, 0.07-0.1kg6 low-substituted hydroxypropyl cellulose and 01.1-0.6kg7 microcrystalline cellulose; After 8 mixtures are stirred, adding 9 ethanol or distilled water carries out stirring until evenly as wetting agent, be made into 10 soft material, 10 soft material go out 12 particles by 14-20 object 11 screen filtration, by 13 dryers, 12 particles are dried, after drying, the standard of 12 particles is water content of 3-10%, adds after 14 dolomol 150-250g mix in 12 particles after oven dry, is pressed into sheet and is made into 15 finished products and orally uses.
Further, in patent of the present invention, 13 dryers remain between 40-100 DEG C the temperature that 12 particles are dried.
Further, utilize the efficient liquid phase spectroscopic methodology of preparation from plant total isoflavone extract, prepared 1 flavone glycoside that concentration is more than or equal to 98% in patent of the present invention.
Further, using method: (first month) 1 time on the 1st, each 2, containing clothes.1 time on the later 1st, each 1, containing clothes
Below be only that embodiment given with reference to the accompanying drawings makes specific descriptions; it is not restriction patent of the present invention being made to its form; concerning the technical scheme of this area, the amendment that the content basis disclosed in patent of the present invention is made, still belongs to the protection domain of art solutions of the present invention.
Claims (5)
1. the preparation method of an anti-ageing plant stem cell lozenge, it adopts flavone glycoside, texifolin, agate coffee and Ka Mu fruit to be raw material, mixture is formed by adding starch, low-substituted hydroxypropyl cellulose and microcrystalline cellulose, after mixture stirs, adding ethanol or distilled water carries out stirring until evenly, be made into soft material, then go out particle by screen filtration as wetting agent, add after dolomol mixes after particle is dried, be pressed into sheet and be made into finished product; Described flavone glycoside is 500g, texifolin is 250-500g, be more than or equal to the agate coffee of 98% concentration is that 250-500g and Ka Mu is really for 500g is raw material; Described starch is 2.5-5kg, low-substituted hydroxypropyl cellulose is 0.07-0.1kg and microcrystalline cellulose is 0.6kg.
2. the preparation method of a kind of anti-ageing plant stem cell lozenge according to claim 1, is characterized in that described screen cloth is 14-20 order.
3. the preparation method of a kind of anti-ageing plant stem cell lozenge according to claim 1, the standard that it is characterized in that drying rear particle is the water content of 3-10%.
4. the preparation method of a kind of anti-ageing plant stem cell lozenge according to claim 1, is characterized in that described dolomol is 150-250g.
5. the preparation method of a kind of anti-ageing plant stem cell lozenge according to claim 1, is characterized in that dryer remains between 40-100 DEG C the temperature that particle is dried.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310080993.3A CN104041803B (en) | 2013-03-14 | 2013-03-14 | A kind of anti-ageing plant stem cell lozenge and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310080993.3A CN104041803B (en) | 2013-03-14 | 2013-03-14 | A kind of anti-ageing plant stem cell lozenge and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104041803A CN104041803A (en) | 2014-09-17 |
| CN104041803B true CN104041803B (en) | 2015-12-02 |
Family
ID=51495670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310080993.3A Expired - Fee Related CN104041803B (en) | 2013-03-14 | 2013-03-14 | A kind of anti-ageing plant stem cell lozenge and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104041803B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020117309A1 (en) * | 2018-12-06 | 2020-06-11 | Rahimi Maryam | Plant stem cell product treatments |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101317665A (en) * | 2007-06-04 | 2008-12-10 | 冷雪飞 | Alkalescent high-energy agent for health and long life of human |
| CN102318795A (en) * | 2011-10-19 | 2012-01-18 | 郭景龙 | Health-care food having anti-fatigue function |
| CN102949431A (en) * | 2012-11-01 | 2013-03-06 | 上海中海龙高新技术研究院 | Maca buccal tablets and preparation method thereof |
-
2013
- 2013-03-14 CN CN201310080993.3A patent/CN104041803B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101317665A (en) * | 2007-06-04 | 2008-12-10 | 冷雪飞 | Alkalescent high-energy agent for health and long life of human |
| CN102318795A (en) * | 2011-10-19 | 2012-01-18 | 郭景龙 | Health-care food having anti-fatigue function |
| CN102949431A (en) * | 2012-11-01 | 2013-03-06 | 上海中海龙高新技术研究院 | Maca buccal tablets and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104041803A (en) | 2014-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kiew et al. | Jewel of the seabed: sea cucumbers as nutritional and drug candidates | |
| Zhang et al. | Antidiabetic properties of polysaccharide-and polyphenolic-enriched fractions from the brown seaweed Ascophyllum nodosum | |
| NZ602249A (en) | Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders | |
| CN103584256B (en) | Natural food preservative prepared by utilizing ulva resource development and preparation method | |
| Kim et al. | Skin whitening and anti-corrugation activities of glycoprotein fractions from liquid extracts of boiled sea cucumber | |
| Bi et al. | Biological and physicochemical properties of two polysaccharides from the mycelia of Grifola umbellate | |
| CN105795301A (en) | Solid beverage with functions of removing toxins and lowering lipid as well as preparation method of solid beverage | |
| CN104041803B (en) | A kind of anti-ageing plant stem cell lozenge and preparation method thereof | |
| CN102784078B (en) | Compound of pine pollen and bamboo leaf extract, application thereof and talcum powder | |
| Ya et al. | Research Article Antioxidant and Antitumor Effect of Different Fractions of Ethyl Acetate Part from Elaeagnus angustifolia L. | |
| Laux et al. | In vitro evaluation of the anti-melanoma effects (A375 cell line) of the gel and whole leaf extracts from selected aloe species | |
| CN104886591A (en) | Selenium-enriched mushroom food additive and preparation method thereof | |
| Iji et al. | Prebiotic properties of algae and algae-supplemented products | |
| CN102845594B (en) | Low-cholesterol animal health product | |
| CN103120308B (en) | Nutritional instant food and preparation method thereof | |
| Vijayalakshmi et al. | Effect of bitter gourd and spent turmeric on glycoconjugate metabolism in streptozotocin-induced diabetic rats | |
| CN105054041A (en) | Fatigue preventing maca tablet | |
| CN102908614A (en) | Antioxidant health-care product containing SOD (Superoxide Dismutase) mixed with plant extract | |
| CN111280437A (en) | Selenium-containing health product and application thereof | |
| CN102048175A (en) | Health food with beautifying efficacy and preparation method thereof | |
| CN107397740A (en) | A kind of antitumor polyphenol compositions of Synergistic and application | |
| Hwang et al. | Protective effect of polysaccharide from Hizikia fusiformis against ethanol-induced toxicity | |
| KR102490378B1 (en) | Composition for enhancement of exercise performance comprising Gynostemma pentaphyllum extracts as an active ingredient | |
| Elaıbı et al. | A comprehensive review of Aloe vera: Multifaceted health benefits and anti-diabetic properties | |
| Kannan et al. | An in vitro study on the antidiabetic effect on red sea weed (Ceramium rubrum). |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| DD01 | Delivery of document by public notice |
Addressee: Ye Ning Document name: Notification of Passing Examination on Formalities |
|
| SE01 | Entry into force of request for substantive examination | ||
| DD01 | Delivery of document by public notice |
Addressee: Ye Ning Document name: Notification of Publication of the Application for Invention Addressee: Ye Ning Document name: Notification of Patent Invention Entering into Substantive Examination Stage |
|
| ASS | Succession or assignment of patent right |
Owner name: GUANGZHOU DANXI BIOLOGICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: YE NING Effective date: 20150217 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 314199 JIAXING, ZHEJIANG PROVINCE TO: 510507 GUANGZHOU, GUANGDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20150217 Address after: 510507 C08 room, two floor, Xinghua Road, No. 30, Xinghua Road, Guangdong, Guangzhou, Tianhe District Applicant after: GUANGZHOU DANXI BIOTECHNOLOGY CO., LTD. Address before: Jiashan County of Jiaxing City, Zhejiang province 314199 Weitang Town Ruixing Lily Spring District 6 Building 1 unit 603 room Applicant before: Ye Ning |
|
| ASS | Succession or assignment of patent right |
Owner name: YE NING Free format text: FORMER OWNER: GUANGZHOU DANXI BIOLOGICAL TECHNOLOGY CO., LTD. Effective date: 20150429 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 510507 GUANGZHOU, GUANGDONG PROVINCE TO: 100023 CHAOYANG, BEIJING |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20150429 Address after: 100023, building 3, building 3, 209 broad road, Beijing, Chaoyang District Applicant after: Ye Ning Address before: 510507 C08 room, two floor, Xinghua Road, No. 30, Xinghua Road, Guangdong, Guangzhou, Tianhe District Applicant before: GUANGZHOU DANXI BIOTECHNOLOGY CO., LTD. |
|
| DD01 | Delivery of document by public notice |
Addressee: Ye Ning Document name: Notification of Passing Examination on Formalities |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151202 Termination date: 20200314 |